These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 4537488)

  • 21. Collaborative study for the calibration of a replacement International Standard for Tetanus Toxoid Adsorbed.
    Tierney R; Stickings P; Hockley J; Rigsby P; Iwaki M; Sesardic D
    Biologicals; 2011 Nov; 39(6):404-16. PubMed ID: 21985899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The reduction of animal usage by the application of indirect haemagglutination in the potency testing of diphtheria toxoid in combined vaccines.
    Maheshwari SC; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1988 Jan; 16(1):9-14. PubMed ID: 3258309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative approach and evaluation of three potency assay methods for testing adsorbed tetanus toxoid.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Mar; 30(1):12-8. PubMed ID: 9842159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A consideration of some methods by which the cost of potency assays for diphtheria and tetanus vaccines might be reduced.
    Knight PA
    Dev Biol Stand; 1978; 41():67-72. PubMed ID: 753671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suitability of the Vero cell method for titration of diphtheria antitoxin in the United States potency test for diphtheria toxoid.
    Gupta RK; Higham S; Gupta CK; Rost B; Siber GR
    Biologicals; 1994 Mar; 22(1):65-72. PubMed ID: 8068315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The kinetics of vaccine antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogeneic and autologous bone marrow transplantation and revaccination. 3: The kinetics of vaccine antibodies against tetanus toxoid and diphtheria toxoid after allogeneic and autologous bone marrow transplantation and combined revaccination against diphtheria and tetanus].
    Prager J; Baumert A; Thilo W; Hermann J; Fuchs D; Sauerbrey A; Zintl F
    Kinderarztl Prax; 1992 Nov; 60(8):230-8. PubMed ID: 1469826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
    Gupta RK; Griffin P; Rivera R; Siber GR
    Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined diphtheria-tetanus immunization of adults.
    Trinca JC
    Med J Aust; 1975 Oct; 2(14):543-6. PubMed ID: 1196209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of the in vitro toxin binding inhibition (ToBI) test for the estimation of the potency of tetanus toxoid.
    Hendriksen CF; van der Gun JW; Marsman FR; Kreeftenberg JG
    Biologicals; 1991 Jan; 19(1):23-9. PubMed ID: 2049173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Collaborative study for the calibration of a replacement international standard for diphtheria toxoid adsorbed.
    Stickings P; Rigsby P; Coombes L; Malik K; Matejtschuk P; Sesardic D
    Biologicals; 2010 Sep; 38(5):529-38. PubMed ID: 20646934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological standardization of potency testing of diphtheria-tetanus-pertussis vaccines.
    Csizér Z; Zsidai J
    Ann Immunol Hung; 1979; 19():53-74. PubMed ID: 552225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a mouse model to estimate the potency of the diphtheria toxoid component of diphtheria-tetanus and diphtheria-tetanus-pertussis vaccines.
    Maheshwari SC; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1988 Jul; 16(3):139-46. PubMed ID: 3170614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potency assay of diphtheria and tetanus toxoids some theoretical and practical considerations.
    Lyng J
    Dev Biol Stand; 1986; 64():47-50. PubMed ID: 3792657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of national standards in the control of standardization of diphtheria and tetanus anatoxins. Conditions of measurement in international units and immunogenic value of tetanus anatoxin for guinea pigs and mice].
    Demian L; Lazăr M
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):297-302. PubMed ID: 5400034
    [No Abstract]   [Full Text] [Related]  

  • 35. [Combined pertussis-tetanus-diphtheria-polio vaccine. Laboratory tests].
    Schiller B; Grodzicka WB; Rudnicka W
    Med Dosw Mikrobiol; 1973; 25(3):231-8. PubMed ID: 4760226
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduction in animal usage for potency testing of diphtheria and tetanus toxoids.
    Stainer DW; Jakus CM; Sparkes JD
    Dev Biol Stand; 1986; 65():241-4. PubMed ID: 3556773
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of reductions in the numbers of animals used for the potency assay of the diphtheria and tetanus components of adsorbed vaccines by the methods of the European pharmacopoeia.
    Hendriksen CF; van der Gun JW; Marsman FR; Kreeftenberg JG
    J Biol Stand; 1987 Oct; 15(4):353-62. PubMed ID: 3680303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vero cell assay validation of an alternative to the Ph. Eur. diphtheria potency tests.
    Gommer AM
    Dev Biol Stand; 1996; 86():217-24. PubMed ID: 8785952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potency testing of diphtheria and tetanus toxoids. A reliable, pragmatic and economic approach.
    Stainer DW
    Dev Biol Stand; 1996; 86():303-8. PubMed ID: 8785960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of immune responses to diphtheria and tetanus toxoids of various mouse strains.
    Kameyama S; Nagaoka F; Matuhasi T
    Jpn J Med Sci Biol; 1989 Jun; 42(3):83-99. PubMed ID: 2630688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.